CLS Holdings USA Inc (CLSH)
0.054
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:59
CLS Holdings USA Revenue (TTM): 20.82M for Feb. 29, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | 20.82M |
| November 30, 2023 | 21.33M |
| August 31, 2023 | 22.20M |
| May 31, 2023 | 23.13M |
| February 28, 2023 | 23.72M |
| November 30, 2022 | 23.87M |
| August 31, 2022 | 23.21M |
| May 31, 2022 | 22.66M |
| February 28, 2022 | 22.56M |
| November 30, 2021 | 21.52M |
| Date | Value |
|---|---|
| August 31, 2021 | 21.01M |
| May 31, 2021 | 19.29M |
| February 28, 2021 | 16.01M |
| November 30, 2020 | 14.69M |
| August 31, 2020 | 12.84M |
| May 31, 2020 | 11.92M |
| February 29, 2020 | 12.07M |
| November 30, 2019 | 11.22M |
| August 31, 2019 | 10.14M |
| May 31, 2019 | 8.459M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.459M
Minimum
May 2019
23.87M
Maximum
Nov 2022
18.13M
Average
20.91M
Median
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |